Our Members
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives, with a focus on infection prevention.
The company is developing novel antimicrobial drugs from its ‘in-house’ XF platform and also from acquired biotherapeutic products that harness beneficial components of the human microbiome. They have two exciting late-stage clinical assets and a range of earlier research programmes.